DHR

Danaher Corporation

Healthcare›Medical - Diagnostics & Research|New York Stock Exchange|US

Price

$191.12

Market Cap

$135.15B

Beta

0.99

P/E

37.9

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+2.90%

EPS Growth (YoY)-4.55%

Revenue CAGR 3Y-6.69%

P/E Ratio37.9

PEG Ratio—

FCF Yield+3.89%

Debt / Equity0.35

Interest Coverage19.4x

No credit card required

Already have an account? Sign in to view the full analysis for DHR.